We report a case of post-artesunate delayed haemolysis (PADH) in severe Plasmodium falciparum malaria.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Packowski M, Landman K, Arguin P. Update on cases of delayed haemolysis after parenteral artesunate therapy for malaria-United States, 2008 and 2013. MMWR 2014; 63: 753-755.
- 2. Askling HH, Bruneel F, Burchard G, et al. Management of imported malaria in Europe. Malar J 2012, 11: 328.
- 3. Rehman K, Lotsch F, Kremsner PG, Ramharter M. Haemolysis associated with the treatment of malaria with artemisinin derivatives: a systematic review of current evidence. Int J Infect Dis. 2014; 29: 268-273.
- 4. Plewes K, Haider MS, Kingston HW, et al. Severe falciparum malaria treated with artesunate complicated by delayed onset haemolysis and acute kidney injury. Malar J 2015; 14: 246.
- 5. Lee J, Krajden S, Graham C, et al. Severe delayed haemolysis associated with regulated parenteral antimalarial drug. Emerg Infect Dis 2015; 21: 164-166.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
No relevant disclosures.